Clinical Trials Logo

Clinical Trial Summary

This prospective observational study aims to compare days alive and out of hospital at 30 days (DAOH-30) in patients with poor or good functional capacity undergoing gastrointestinal surgeries. The investigators are testing the hypothesis that patients with good functional capacity will have longer days alive and out of hospital than those with poor.


Clinical Trial Description

Days Alive and Out of Hospital (DAOH) is a composite patient-centered outcome that integrates three critical clinical outcomes: death, hospital length of stay, and hospital readmission. It is associated with patient comorbidities, surgical complexity, and postoperative complications. Evaluation of functional capacity before noncardiac surgery is recommended to identify the perioperative risks. Duke Activity Status Index (DASI) is one of the tools for determining functional capacity; the scores are between 0 and 58,2, and high scores are related to improved capacity. A DASI score of 34 and below was found to be a risk for moderate to severe complications and new disability. The primary aim is to compare days alive and out of the hospital at 30 days in patients ≤ 34 and above 34 DASI scores. The secondary aims are to evaluate intensive care unit (ICU) need and duration, length of hospital stay, rehospitalization, postoperative complications, morbidity, and mortality in patients with DASI scores ≤ 34 and above 34. Days alive and out of hospital at 90 days will be compared in both groups as a secondary outcome. The investigators will also analyze the possible perioperative factors affecting the days alive and out of the hospital outcome. Before the operation, the patients will answer the DASI questionnaire in the waiting area of the operating theatres. The patients will be divided into two groups according to the DASI score (Poor functional capacity: ≤ 34 points, good functional capacity: above 34 points). Patient and surgical characteristics (comorbidities, American Society of Anesthesiologists physical status classification, laboratory values before the operation, frailty index value, American College of Surgeons Risk Calculator outcomes, surgery type, length of operation, intraoperative complications), ICU need and duration will be recorded. Postoperative complications ( cardiovascular, pulmonary, renal, neurologic, surgical, infectious, and wound ), the Postoperative Morbidity Survey (POMS) related morbidity and mortality on the 30th day will be investigated. Length of hospital stay starting with index surgery, rehospitalization and duration of further stays will be recorded. Days Alive and Out of Hospital at 30 days (DAOH-30) will be calculated using mortality, hospital length of stay, and readmissions between the date of the index surgery and the 30th postoperative day. 90th-day mortality and Days Alive and Out of Hospital at 90 days (DAOH-90) will also be investigated. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06316245
Study type Observational [Patient Registry]
Source Istanbul University
Contact Muserref B Dincer
Phone +905321624712
Email mberildincer@gmail.com
Status Recruiting
Phase
Start date March 19, 2024
Completion date December 19, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT05847296 - Effect of Preoperative Sarcopenia on Postoperative Delirium in Elderly Patients Undergoing Gastrointestinal Surgery
Completed NCT05576675 - Patient-controlled Intravenous Analgesia Combined With Different Opioid Receptors for Gastrointestinal Surgery Phase 3
Recruiting NCT00995735 - IMTN Study- International Prospective Multicenter Trial on Clinical NOTES N/A
Completed NCT00732849 - The Impact of the Type and Route of Nutritional Support on Infectious Complications After Upper Gastrointestinal Surgery Phase 4
Recruiting NCT05445024 - Combination of Nalbuphine and Dexmedetomidine Versus Sufentanil and Dexmedetomidine on Patients N/A
Completed NCT03204344 - Preoperative Oral Carbohydrate and Postoperative Recovery in Diabetic Patients N/A
Completed NCT02135016 - The Effect of Thoracic Epidural Anesthesia With Different Block Level on Propofol Induction Phase 4